Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Faina Vikhanskaya
Observed names:
F L Vikhanskaya,
F Vikhanskaya,
F. L. Vikhanskaya,
F. Vikhanskaya,
F.L. Vikhanskaya,
FL Vikhanskaya,
Vikhanskaya, Faina
show all 7
Observed institutions:
Mario Negri Institute for Pharmacological Research,
Institute of Cytology,
Institute of Molecular Genetics,
National Cancer Centre Singapore,
Academy of Sciences of the Soviet Union
OpenAlex ID:
A5108271826
c-Jun promotes cellular survival by suppression of PTEN
2006
·
K Hettinger
, F Vikhanskaya
, et al.
·
Cell Death and Differentiation
·
159
Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53
2007
·
F. Vikhanskaya
, M. K. Lee
, et al.
·
Nucleic Acids Research
·
146
PDF
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel.
1997
·
D Debernardis
, E G Siré
, et al.
·
PubMed
·
146
Inactivation of p53 in a Human Ovarian Cancer Cell Line Increases the Sensitivity to Paclitaxel by Inducing G2/M Arrest and Apoptosis
1998
·
Faina Vikhanskaya
, Sara Vignati
, et al.
·
Experimental Cell Research
·
95
Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation
2001
·
Giovanna Damia
, Laura Filiberti
, et al.
·
Neoplasia
·
92
PDF
p53 Regulates the Minimal Promoter of the Human Topoisomerase II Gene
1996
·
M. I. Sandri
, R. J. Isaacs
, et al.
·
Nucleic Acids Research
·
91
PDF
Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
1998
·
L Giorello
, L Clerico
, et al.
·
PubMed
·
82
Variolin B and its derivate deoxy-variolin B: New marine natural compounds with cyclin-dependent kinase inhibitor activity
2005
·
Matteo Simone
, Eugenio Erba
, et al.
·
European Journal of Cancer
·
81
Evaluation of the Combined Effect of p53 Codon 72 Polymorphism and Hotspot Mutations in Response to Anticancer Drugs
2005
·
Faina Vikhanskaya
, Mobin M. Siddique
, et al.
·
Clinical Cancer Research
·
75
p73 supports cellular growth through c-Jun-dependent AP-1 transactivation
2007
·
Faina Vikhanskaya
, Wen Hong Toh
, et al.
·
Nature Cell Biology
·
67
P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line.
2001
·
F Vikhanskaya
, S Marchini
, et al.
·
PubMed
·
57
Characterization of the 5’flanking Region of the Human chk1 Gene: Identification of E2F1 Functional Sites
2003
·
Laura Carrassa
, Massimo Broggini
, et al.
·
Cell Cycle
·
53
PDF
p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis
2001
·
Faina Vikhanskaya
, Maria R Bani
, et al.
·
Oncogene
·
52
p73 competes with p53 and attenuates its response in a human ovarian cancer cell line
2000
·
F. Vikhanskaya
·
Nucleic Acids Research
·
52
Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53
1994
·
Faina Vikhanskaya
, Eugenio Erba
, et al.
·
Nucleic Acids Research
·
49
Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage.
1999
·
F Vikhanskaya
, G Colella
, et al.
·
PubMed
·
46
p73: A chiaroscuro gene in cancer
2007
·
Mirko Marabese
, Faina Vikhanskaya
, et al.
·
European Journal of Cancer
·
44
Decreased cytotoxic effects of doxorubicin in a human ovarian cancer‐cell line expressing wild‐type p53 and WAF1/CIP1 genes
1995
·
Faina Vikhanskaya
, Maurizio D'Incalcimassimo Broggini
·
International Journal of Cancer
·
35
HtrA2 enhances the apoptotic functions of p73 on bax
2008
·
M Marabese
, M Mazzoletti
, et al.
·
Cell Death and Differentiation
·
29
Human papillomavirus type 16 E6‐enhanced susceptibility to apoptosis induced by TNF in A2780 human ovarian cancer cell line
2001
·
Faina Vikhanskaya
, Carla Falugi
, et al.
·
International Journal of Cancer
·
27
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53
1997
·
Faina Vikhanskaya
, Luana Clerico
, et al.
·
International Journal of Cancer
·
26
PDF
Sensitivity and cellular response to different anticancer agents of a human ovarian cancer cell line expressing wild-type, mutated or no p53
1995
·
E.A. Graniela Siré
, F. Vikhanskaya
, et al.
·
Annals of Oncology
·
26
Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid
1994
·
E Erba
, S Sen
, et al.
·
British Journal of Cancer
·
20
Effects of inducible overexpression of DNp73α on cancer cell growth and response to treatment in vitro and in vivo
2005
·
M Marabese
, S Marchini
, et al.
·
Cell Death and Differentiation
·
17
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res.
1997
·
Domizia Debernardis
, Eva Graniela Siré
, et al.
·
16
Show more works
View as search
Works count:
43
Citation count:
1,613
H-index:
22
I10-index:
26
Year
Topic
Type